NeuroAI NEUROAINEUROAI.SITE
China AI, reported clearly
1,300+ verified stories on models, robotics, BCI and the business of AI.
Browse stories
ESC

A 20 Million Yuan Ticket to the Robotics Industry: Worth It?

Daily AI industry briefing from Brain-Computer Network: verified facts, sourced numbers.

2026-11-13 · 624 words · NeuroAI
A 20 Million Yuan Ticket to the Robotics Industry: Worth It?

On the evening of November 12, Wanan Technology answered an investor question on the Shenzhen exchange's interactive platform: with the robotics sector running hot, does the company have a position?

The reply was candid. Wireless charging products from its associate company Yichuang Zhilian are used in industrial mobile robots and service robots. Separately, the company has made a strategic investment in Tongchuan Technology, which builds core robot components, and will pay close attention to robotics opportunities as it extends from automotive precision manufacturing.

The 20 Million Yuan Bet

The core of that layout is one capital injection. According to China Securities Journal, Wanan announced in September 2025 a 20 million yuan capital increase into Tongchuan, taking a 2.72 percent stake at a pre-money valuation of 700 million yuan.

Measured against the company's own books, the bet is light. Wanan reported 4.96 billion yuan of revenue and 213 million yuan of net profit attributable to shareholders in 2025; 20 million yuan is under a tenth of one year's profit.

But the position is well chosen. Tongchuan's core products are harmonic reducers, robot joints and mechatronic actuators. Its harmonic reducers and integrated joints have been qualified by robot makers including Luoshi, Yuejiang, Ailite, Fourier, Haifeng and Peitian.

Reducers are among the core components of a humanoid robot. The ticket was bought at a link in the chain that industrial customers have already validated.

The Core Business Carries the Base

Wanan's main business is automotive chassis control systems. The third-quarter report shows revenue of 3.643 billion yuan for the first three quarters, up 5.28 percent year on year, with attributable net profit of 149 million yuan, up 0.34 percent. The third quarter alone brought 1.351 billion yuan of revenue, up 4.29 percent, and attributable net profit of 60.87 million yuan, down 3.13 percent.

The interim report's breakdown: pneumatic braking at 31.75 percent of revenue, hydraulic braking at 29.30 percent, subframes at 29.09 percent. A classic auto-parts profile, with no separately disclosed robotics revenue line and no earnings contribution yet.

How to Read It

Wanan closed at 9.93 yuan on November 12, down 2.84 percent, for a market capitalization of about 5.15 billion yuan.

The story is not on the income statement; a 2.72 percent stake contributes little today. The value is optionality. If Tongchuan scales with the humanoid robot industry, the ticket appreciates; if the industry disappoints, the loss is capped at 20 million yuan.

What to watch is escalation. The platform reply's language, "pay close attention" and "extend," is wait-and-see grade; every step from 2.72 percent toward control or additional investment would be the real upgrade signal.

Zheshang Securities' recent sector view holds that humanoid robotics is extending from hardware mass-production validation toward embodied models and data collection, with hardware production certainty still the main line. Wanan's bet sits on the most validated link of that line.

The balance sheet context softens the downside further. Wanan's 2026 interim report showed a conventional auto-parts revenue mix with steady domestic sales, and the company's public filings carry no robotics-linked revenue disclosure, meaning the market is not currently paying for the option it holds. If Tongchuan never scales, the stake likely remains a footnote in an annual report; if humanoid production volumes climb the way industry forecasts suggest, a 2.72 percent position in a qualified reducer supplier becomes a visible asset on the books. The asymmetry, small defined downside against an industry-linked upside, is the actual investment case here.

Risk note: this article summarizes public information; robotics has no measurable impact on the company's earnings yet, and related plans carry uncertainty. Figures come from company filings and exchange-disclosed reports.

Disclaimer: This article is based on public information and is for reference only. It does not constitute any investment advice.

Related coverage

Cite this article

NeuroAI (脑机网), "A 20 Million Yuan Ticket to the Robotics Industry: Worth It?," 13 November 2026, https://neuroai.site/a/na-stock-wanan-technology-robot-entry

Machine-readable: BibTeX · RIS · JSON · Markdown

More in “Foundation Models” → · Back to home · Markdown version

China AI, reported clearly
1,300+ verified stories on models, robotics, BCI and the business of AI.
Browse stories